Google Capital invested $32.5M in Oscar in a deal valuing the health insurance startup at $1.75B
Douglas MacMillan / Wall Street Journal :
Context & Ripple Effects
This round lands just five months after Oscar's $145M raise at a $1.5B valuation, so Google Capital is buying into a company whose price has already stepped up sharply this year — $1.75B on a $32.5M check signals a late-stage-style entry rather than an early bet.
What makes it more than another insurance round is who is writing the check: Google Capital's move foreshadows the deeper Alphabet relationship that followed, with Capital G and Verily joining Oscar's $165M Founders Fund-led round in 2018 and Alphabet itself investing $375M later that year.
First-order effects
- Oscar gains a strategic backer with data infrastructure ambitions, and its valuation rises from $1.5B to $1.75B within months of its previous financing.
Second-order effects
- Google Capital's entry validates the direct-to-consumer insurance model for other growth investors, opening the door to the succession of nine-figure rounds Oscar raised through 2020 — including $225M against what it called a $2B revenue base and a $140M Tiger Global round.
Third-order effects
- The pattern holds all the way to an exit: sustained big-tech-plus-growth funding carried Oscar to a $39-per-share IPO raising $1.44B at a $9.5B valuation — evidence that consumer health insurers could be financed as technology platforms, with Alphabet's escalating stakes as the template.
The trend: Growth-stage tech capital is treating health insurance as a data business, with Alphabet-linked funds moving from minority checks to deep ownership positions in Oscar.